JAMA Network Home
Sign In
Invited Commentary

Dual Immune Checkpoint Blockade in Microsatellite Instability-High Cancers—Effective, but for Whom and When?

JAMA Oncology 10.1001/jamaoncol.2025.4612

November 13, 2025 at 11:00 AM EST

Read the full article

Corresponding Author: Casey M Cosgrove, MD, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, The James Cancer Hospital and Solove Research Institute, M-210 Starling-Loving, 320 W 10th Ave, Columbus, OH 43210-3078 (casey.cosgrove@osumc.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.4612?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111325

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks